Expert faculty will discuss the use of deep neuromuscular blockade to facilitate optimal surgical conditions and provide learners with strategies to effectively utilize best practices in the pharmacologic reversal of neuromuscular blockade ideally guided by quantitative monitoring techniques.

Supported by an educational grant from Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.

Download the Transcript   |  Obtain Credit…